[Federal Register Volume 82, Number 83 (Tuesday, May 2, 2017)]
[Notices]
[Pages 20488-20489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08849]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to The National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on April 10, 2017, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Codagenix, Inc., Great Neck, NY; Fraunhofer USA Center 
for Molecular Biotechnology, Newark, DE; FUJIFILM Pharmaceuticals USA, 
Inc., Boston, MA; Ibis Biosciences Inc., an Abbott Company, Carlsbad, 
CA; Biomeme, Inc., Philadelphia, PA; PPD Development LP, Wilmington, 
NC; California Institute for Biomedical Research, La Jolla, CA; Leidos, 
Inc., Reston, VA; Merck Research Laboratories, Whitehouse Station, NJ; 
Tetracore, Inc., Rockville, MD; Mesa Tech International, San Diego, CA; 
Synthetic Genomics Vaccines, Inc., La Jolla, CA; Brimrose Technology 
Corporation, Sparks, MD; Bioo Scientific Corporation, Austin, TX; Click 
Diagnostics, Inc., San Jose, CA; Pulmotect, Inc., Houston, TX; JYANT 
Technologies, Inc., Marietta, GA; YourEncore, Inc., Indianapolis, IN; 
and Texas Biomedical Research Institute, San Antonio, TX, have been 
added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.

[[Page 20489]]

    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on February 3, 
2017. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on March 7, 2017 (82 FR 12847).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-08849 Filed 5-1-17; 8:45 am]
 BILLING CODE P